17:35:39 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference

2018-01-03 08:00 ET - News Release

Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference

Canada NewsWire

LAVAL, Quebec, Jan. 3, 2018 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 10, 2018, at 10:30 a.m. PST (1:30 p.m. EST).

A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at: http://ir.valeant.com/events-and-presentations/2018.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Investor Contact:       

Media Contact:

Arthur Shannon         

Lainie Keller

arthur.shannon@valeant.com     

lainie.keller@valeant.com

(514) 856-3855                  

(908) 927-0617

(877) 281-6642 (toll free)       


 

Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300574997.html

SOURCE Valeant Pharmaceuticals International, Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/January2018/03/c1108.html

© 2024 Canjex Publishing Ltd. All rights reserved.